BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35274851)

  • 1. [The role of angiotensin-converting enzyme and angiotensin ii receptors of the second type in the pathogenesis of proliferative diseases of the prostate].
    Chibichyan MB; Chernogubova EA; Avetyan AV; Lapteva TO; Pavlenko IA; Kogan MI
    Urologiia; 2022 Mar; (1):5-10. PubMed ID: 35274851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER].
    Kogan MI; Chernogubova EA; Chibichjan MB; Macionis AJ; Povilajtite PJ; Matishov DG
    Urologiia; 2015; (3):50-4. PubMed ID: 26390560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
    Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury.
    Ghosh S; Sica D; Schoolwerth AC; Quigg RJ; Haas M; Fakhry I; Gehr TW
    Am J Med Sci; 2002 Dec; 324(6):296-304. PubMed ID: 12495295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenotyping of angiotensin-converting enzyme in the prostate in patients with prostate cancer and benign prostatic hyperplasia].
    Mamedov VN; Danilov SM; Samokhodskaya LM; Okhobotov DA; Kamalov DM; Melnikov N; Karpov VK; Kadrev AV; Kamalov AA
    Urologiia; 2020 Nov; (5):20-27. PubMed ID: 33185341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice.
    Hunley TE; Tamura M; Stoneking BJ; Nishimura H; Ichiki T; Inagami T; Kon V
    Kidney Int; 2000 Feb; 57(2):570-7. PubMed ID: 10652034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors.
    Zhuo J; Moeller I; Jenkins T; Chai SY; Allen AM; Ohishi M; Mendelsohn FA
    J Hypertens; 1998 Dec; 16(12 Pt 2):2027-37. PubMed ID: 9886893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Protective Arm of Renin Angiotensin System; Recent Research Progress and Expectation for New Therapeutic Approach].
    Horiuchi M
    Nihon Rinsho; 2016 Sep; 74(9):1583-1589. PubMed ID: 30557497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.
    Dinh DT; Frauman AG; Somers GR; Ohishi M; Zhou J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2002 Feb; 196(2):213-9. PubMed ID: 11793373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embarking Effect of ACE2-Angiotensin 1-7/Mas Receptor Axis in Benign Prostate Hyperplasia.
    Singh Y; Gupta G; Sharma R; Matta Y; Mishra A; Pinto TJA; Dua K
    Crit Rev Eukaryot Gene Expr; 2018; 28(2):115-124. PubMed ID: 30055537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of prostatic growth, pathogenesis of prostatic adenoma and cancer].
    Darenkov AF; Evdokimov VV; Alfimov AE
    Vestn Ross Akad Med Nauk; 1994; (11):50-9. PubMed ID: 7530531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system is an important factor in hormone refractory prostate cancer.
    Uemura H; Hasumi H; Ishiguro H; Teranishi J; Miyoshi Y; Kubota Y
    Prostate; 2006 Jun; 66(8):822-30. PubMed ID: 16482568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands.
    Cano IP; Dionisio TJ; Cestari TM; Calvo AM; Colombini-Ishikiriama BL; Faria FAC; Siqueira WL; Santos CF
    PLoS One; 2019; 14(5):e0217030. PubMed ID: 31116771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of renin-angiotensin-aldosterone system in human adipose tissues].
    Zhang XH; Zeng ZP; Li HZ; Zhou YR; Zhang J; Tong AL; Yan ZL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):766-9. PubMed ID: 17260463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin system plays a major role in voiding dysfunction of ovariectomized rats.
    Ramos-Filho AC; A Faria J; Calmasini FB; Teixeira SA; Mónica FZ; Muscará MN; Gontijo JA; Anhê GF; Zanesco A; Antunes E
    Life Sci; 2013 Nov; 93(22):820-9. PubMed ID: 24050930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
    Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
    Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men.
    Bukowska A; Spiller L; Wolke C; Lendeckel U; Weinert S; Hoffmann J; Bornfleth P; Kutschka I; Gardemann A; Isermann B; Goette A
    Exp Biol Med (Maywood); 2017 Aug; 242(14):1412-1423. PubMed ID: 28661206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
    Mostafa F; Mantawy EM; Azab SS; El-Demerdash E
    Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.